Replies to post #15592 on AEterna Zentaris Inc. (AEZS)

[alexander77]

The rule is that the company has to reach a market cap of at least $300m somewhere between the phase 3 results and the final FDA decision.

[mypekeispooped]

Celator Pharmaceuticals had a successful PIII with a cap of less than 300M. Stock went to $15 and as bought out for about $30 b y JAZZ. "And although JAZZ stock owners may be pinching themselves over the fact that CPXX stock is fetching $30 a share despite trading well below $2/share prior to its Phase-3".